CD8A and neoplasm: The use of hybrid ACT analogues for the presentation of epitopes to CD8+ T cells was then extended to other antigens, including tumour antigens [60], which led to the finding that net negative charges are detrimental to the translocation process and the ensuing induction of CD8+ T-cell responses.